Term and Conditions:-
Venue of the Interview: IDPL Corporate Office:-IDPL Complex, Old Delhi Gurgaon
Road, Dundhahera, Gurgaon - 122016
Place of Work: The place of work will be presently at Corporate Office, Gurgaon However,
the selected candidate may be placed anywhere in India depending on the requirement of the
Company.
General Conditions:
1. The Candidates must ensure that they possess the required qualification and
experience in the relevant field for the post applied.
2. The Documents submitted by the Candidate if found incorrect / false information/
certificate/documents or has suppressed any material fact(s) his/her candidature will
stand cancelled. If any of these short comings is/are detected even after appointment,
his/her services are liable to be terminated.
3. IDPL has right to reject Candidature at any stage and the decision of IDPL will be Final
4. IDPL has right to reject entire selection/advertisement at any stage and the decision of
IDPL shall be final in this regard.
5. Any dispute arising out of this advertisement shall be subject to the sole jurisdiction of
Court situated at respective place of posting.
6. IDPL reserves the right to raise / modify the Eligibility Criteria in educational
qualification/ experience/age in case of requirement and deserving candidates.
7. The above posts purely on contract basis initially for period of one year further
extension subject to performance.
Candidates are required to bring with them:
Eligible/ Interested candidates may bring their applications in prescribed format which
can be downloaded from the website .Candidates may appear in the Walk-In-Interview with
two passport size Photographs ,ID Proof, present salary detail, Original testimonials and a
copies of the testimonials in support of Educational Qualification, age, Experience & Category
etc. If candidate fails to show their original certificates in support to their Educational
Qualification, age, Experience, Category, then the candidature will be rejected.
Thank you for visiting my blog , Visit again for latest pharma
updates